首页> 美国卫生研究院文献>other >The Role of Metabotropic Glutamate Receptor 5 on the Stromal Cell-Derived Factor-1/CXCR4 System in Oral Cancer
【2h】

The Role of Metabotropic Glutamate Receptor 5 on the Stromal Cell-Derived Factor-1/CXCR4 System in Oral Cancer

机译:代谢型谷氨酸受体5在口腔癌基质细胞衍生因子-1 / CXCR4系统中的作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have demonstrated that blocking CXCR4 may be a potent anti-metastatic therapy for CXCR4-related oral cancer. However, as CXCR4 antagonists are currently in clinical use to induce the mobilization of hematopoietic stem cells, continuous administration as an inhibitor for the metastasis may lead to persistent leukocytosis. In this study, we investigated the novel therapeutic downstream target(s) of the SDF-1/CXCR4 system, using B88-SDF-1 cells, which have an autocrine SDF-1/CXCR4 system and exhibit distant metastatic potential in vivo. Microarray analysis revealed that 418 genes were upregulated in B88-SDF-1 cells. We identified a gene that is highly upregulated in B88-SDF-1 cells, metabotropic glutamate receptor 5 (mGluR5), which was downregulated following treatment with 1,1’ -[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane octahydrochloride (AMD3100), a CXCR4 antagonist. The upregulation of mGluR5 mRNA in the SDF-1/CXCR4 system was predominately regulated by the Ras-extracellular signal-regulated kinase (ERK)1/2 pathway. Additionally, the growth of B88-SDF-1 cells was not affected by the mGluR5 agonist (S)-3,5-DHPG (DHPG) or the mGluR5 antagonists 2-Methyl-6-(phenylethynyl)pyridine (MPEP) and 3-((2-Methyl-1,3-thiazol-4-yl)ethynyl)pyridine (MTEP). However, we observed that DHPG promoted B88-SDF-1 cell migration, whereas both MPEP and MTEP inhibited B88-SDF-1 cell migration. To assess drug toxicity, the antagonists were intraperitoneally injected into immunocompetent mice for 4 weeks. Mice injected with MPEP (5 mg/kg) and MTEP (5 mg/kg) did not exhibit any side effects, such as hematotoxicity, allergic reactions or weight loss. The administration of antagonists significantly inhibited the metastasis of B88-SDF-1 cells to the lungs of nude mice. These results suggest that blocking mGluR5 with antagonists such as MPEP and MTEP could prevent metastasis in CXCR4-related oral cancer without causing side effects.
机译:我们已经证明,阻断CXCR4可能是CXCR4相关口腔癌的有效抗转移疗法。然而,由于CXCR4拮抗剂目前在临床上用于诱导造血干细胞的动员,因此连续施用作为转移抑制剂可导致持续性白细胞增多。在这项研究中,我们使用B88-SDF-1细胞研究了SDF-1 / CXCR4系统的新型治疗下游靶标,该细胞具有自分泌SDF-1 / CXCR4系统并在体内具有远处转移的潜力。基因芯片分析显示,B88-SDF-1细胞中有418个基因上调。我们鉴定出一个在B88-SDF-1细胞中高度上调的基因,代谢型谷氨酸受体5(mGluR5),在用1,1'-[1,4-苯撑双(亚甲基)] bis-1,4处理后被下调,8,11-四氮杂环十四烷八盐酸盐(AMD3100),一种CXCR4拮抗剂。 SDF-1 / CXCR4系统中的mGluR5 mRNA的上调主要受Ras-细胞外信号调节激酶(ERK)1/2通路的调节。此外,B88-SDF-1细胞的生长不受mGluR5激动剂(S)-3,5-DHPG(DHPG)或mGluR5拮抗剂2-甲基-6-(苯基乙炔基)吡啶(MPEP)和3- ((2-甲基-1,3-噻唑-4-基)乙炔基)吡啶(MTEP)。但是,我们观察到DHPG促进B88-SDF-1细胞迁移,而MPEP和MTEP均抑制B88-SDF-1细胞迁移。为了评估药物毒性,将拮抗剂腹膜内注射到具有免疫能力的小鼠中4周。注射MPEP(5 mg / kg)和MTEP(5 mg / kg)的小鼠没有表现出任何副作用,例如血液毒性,过敏反应或体重减轻。拮抗剂的施用显着抑制了B88-SDF-1细胞向裸鼠肺部的转移。这些结果表明,用MPEP和MTEP等拮抗剂阻断mGluR5可以预防CXCR4相关口腔癌的转移而不会引起副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号